Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Report 2021
Table of Contents1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Overview
1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Scope
1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Type
1.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016 & 2021 & 2027)
1.2.2 Surgical Treatment
1.2.3 Minimally Invasive Treatment
1.2.4 Laser Treatment
1.2.5 Other
1.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Application
1.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Fertility Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Forecasts (2016-2027)
1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price Trends (2016-2027)
2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Estimates and Forecasts by Region
2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2016-2021)
2.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2016-2021)
2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Estimates and Projections (2016-2027)
2.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Estimates and Projections (2016-2027)
2.4.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Estimates and Projections (2016-2027)
2.4.4 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Estimates and Projections (2016-2027)
2.4.6 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Estimates and Projections (2016-2027)
3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Competition Landscape by Players
3.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Players by Sales (2016-2021)
3.2 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Players by Revenue (2016-2021)
3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Devices as of 2020)
3.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price by Company (2016-2021)
3.5 Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Type
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Review by Type (2016-2021)
4.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2021)
4.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2016-2021)
4.1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2016-2021)
4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2022-2027)
4.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Type (2022-2027)
4.2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price Forecast by Type (2022-2027)
5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Application
5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Review by Application (2016-2021)
5.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2021)
5.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2016-2021)
5.1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2016-2021)
5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2022-2027)
5.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Application (2022-2027)
5.2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price Forecast by Application (2022-2027)
6 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures
6.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company
6.1.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company (2016-2021)
6.1.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021)
6.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type
6.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021)
6.2.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2022-2027)
6.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application
6.3.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application (2016-2021)
6.3.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application (2022-2027)
7 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures
7.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company
7.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company (2016-2021)
7.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021)
7.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type
7.2.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021)
7.2.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2022-2027)
7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures
8.1 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company
8.1.1 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company (2016-2021)
8.1.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021)
8.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type
8.2.1 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021)
8.2.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2022-2027)
8.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures
9.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company
9.1.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company (2016-2021)
9.1.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021)
9.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type
9.2.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021)
9.2.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2022-2027)
9.3 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures
10.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company
10.1.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company (2016-2021)
10.1.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021)
10.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type
10.2.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Facts & Figures
11.1 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company
11.1.1 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company (2016-2021)
11.1.2 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021)
11.2 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type
11.2.1 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2016-2021)
11.2.2 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Type (2022-2027)
11.3 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application
11.3.1 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application (2016-2021)
11.3.2 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Benign Prostatic Hyperplasia (BPH) Treatment Devices Business
12.1 Advin Urology
12.1.1 Advin Urology Corporation Information
12.1.2 Advin Urology Business Overview
12.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.1.5 Advin Urology Recent Development
12.2 Biolitec
12.2.1 Biolitec Corporation Information
12.2.2 Biolitec Business Overview
12.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.2.5 Biolitec Recent Development
12.3 Boston Scientific Corporation
12.3.1 Boston Scientific Corporation Corporation Information
12.3.2 Boston Scientific Corporation Business Overview
12.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.3.5 Boston Scientific Corporation Recent Development
12.4 CONMED
12.4.1 CONMED Corporation Information
12.4.2 CONMED Business Overview
12.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.4.5 CONMED Recent Development
12.5 Convergent Laser Technologies
12.5.1 Convergent Laser Technologies Corporation Information
12.5.2 Convergent Laser Technologies Business Overview
12.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.5.5 Convergent Laser Technologies Recent Development
12.6 CoreTherm Medical, Inc. (ProstaLund)
12.6.1 CoreTherm Medical, Inc. (ProstaLund) Corporation Information
12.6.2 CoreTherm Medical, Inc. (ProstaLund) Business Overview
12.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.6.4 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.6.5 CoreTherm Medical, Inc. (ProstaLund) Recent Development
12.7 HistoSonics, Inc.
12.7.1 HistoSonics, Inc. Corporation Information
12.7.2 HistoSonics, Inc. Business Overview
12.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.7.4 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.7.5 HistoSonics, Inc. Recent Development
12.8 JenaSurgical GmbH
12.8.1 JenaSurgical GmbH Corporation Information
12.8.2 JenaSurgical GmbH Business Overview
12.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.8.4 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.8.5 JenaSurgical GmbH Recent Development
12.9 KARL STORZ
12.9.1 KARL STORZ Corporation Information
12.9.2 KARL STORZ Business Overview
12.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.9.4 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.9.5 KARL STORZ Recent Development
12.10 LISA Laser Products GmbH
12.10.1 LISA Laser Products GmbH Corporation Information
12.10.2 LISA Laser Products GmbH Business Overview
12.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.10.4 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.10.5 LISA Laser Products GmbH Recent Development
12.11 Lumenis Ltd.
12.11.1 Lumenis Ltd. Corporation Information
12.11.2 Lumenis Ltd. Business Overview
12.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.11.5 Lumenis Ltd. Recent Development
12.12 Medifocus, Inc.
12.12.1 Medifocus, Inc. Corporation Information
12.12.2 Medifocus, Inc. Business Overview
12.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.12.5 Medifocus, Inc. Recent Development
12.13 Endo International
12.13.1 Endo International Corporation Information
12.13.2 Endo International Business Overview
12.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.13.5 Endo International Recent Development
12.14 Medtronic
12.14.1 Medtronic Corporation Information
12.14.2 Medtronic Business Overview
12.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.14.5 Medtronic Recent Development
12.15 Siemens
12.15.1 Siemens Corporation Information
12.15.2 Siemens Business Overview
12.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.15.5 Siemens Recent Development
12.16 Olympus
12.16.1 Olympus Corporation Information
12.16.2 Olympus Business Overview
12.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.16.5 Olympus Recent Development
12.17 Urologix
12.17.1 Urologix Corporation Information
12.17.2 Urologix Business Overview
12.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.17.5 Urologix Recent Development
12.18 NeoTract
12.18.1 NeoTract Corporation Information
12.18.2 NeoTract Business Overview
12.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.18.4 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.18.5 NeoTract Recent Development
12.19 Urotech
12.19.1 Urotech Corporation Information
12.19.2 Urotech Business Overview
12.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.19.5 Urotech Recent Development
12.20 Baxter International
12.20.1 Baxter International Corporation Information
12.20.2 Baxter International Business Overview
12.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
12.20.5 Baxter International Recent Development
13 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Cost Analysis
13.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
13.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List
14.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers
15 Market Dynamics
15.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Trends
15.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Drivers
15.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Challenges
15.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of TablesTable 1. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Region (2016-2021)
Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2016-2021)
Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Region (2016-2021)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share Forecast by Region (2022-2027)
Table 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Company (2016-2021)
Table 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Company (2016-2021)
Table 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Devices as of 2020)
Table 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Sites and Area Served
Table 19. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2016-2021)
Table 22. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Type (2016-2021)
Table 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Type (2016-2021)
Table 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Type (2022-2027)
Table 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Type (2022-2027)
Table 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Type (2022-2027)
Table 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application (2016-2021)
Table 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Application (2016-2021)
Table 31. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Application (2016-2021)
Table 33. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application (2022-2027)
Table 34. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Application (2022-2027)
Table 35. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Application (2022-2027)
Table 37. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit) by Application (2022-2027)
Table 38. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Company (2016-2021)
Table 39. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company (2016-2021)
Table 40. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company (2016-2021)
Table 42. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (K Units)
Table 43. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2021)
Table 44. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2022-2027) & (K Units)
Table 45. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2022-2027)
Table 46. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (K Units)
Table 47. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2021)
Table 48. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2022-2027) & (K Units)
Table 49. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2022-2027)
Table 50. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Company (2016-2021)
Table 51. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company (2016-2021)
Table 52. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company (2016-2021)
Table 54. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (K Units)
Table 55. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2021)
Table 56. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2022-2027) & (K Units)
Table 57. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2022-2027)
Table 58. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (K Units)
Table 59. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2021)
Table 60. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2022-2027) & (K Units)
Table 61. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2022-2027)
Table 62. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Company (2016-2021)
Table 63. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company (2016-2021)
Table 64. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company (2016-2021)
Table 66. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (K Units)
Table 67. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2021)
Table 68. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2022-2027) & (K Units)
Table 69. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2022-2027)
Table 70. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (K Units)
Table 71. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2021)
Table 72. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2022-2027) & (K Units)
Table 73. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2022-2027)
Table 74. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Company (2016-2021)
Table 75. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company (2016-2021)
Table 76. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company (2016-2021)
Table 78. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (K Units)
Table 79. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2021)
Table 80. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2022-2027) & (K Units)
Table 81. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2022-2027)
Table 82. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (K Units)
Table 83. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2016-2021)
Table 84. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2022-2027) & (K Units)
Table 85. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2016-2021) & (K Units)
Table 95. Southea